5 results
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Tuberculosis - IDSA ... Guidelines # ... #medications #pharmacology ... #IDSA #Guidelines
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... MDR-TB) • Build a regimen ... clarithromycin #MultiDrugResistant ... #pharmacology # ... dosing #idsa #drugs
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
fluoroquinolone #IDSA ... #Outpatient #CAP ... Antibiotics #Treatment #Regimen ... #Management #Guidelines ... #pharmacology
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... recommendations on drugs ... in a treatment regimen ... Delamanid #MultiDrugResistant ... antimicrobials #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... RAL-based ART regimen ... Adolescent ARV Guidelines ... Tuberculosis #TB #IDSA ... infections #HIVAIDS #pharmacology